Congratulations (paper published)

Congratulations to our members for their recent publication.┬áDroxidopa has been approved for the treatment of neurogenic orthostatic hypotension (NOH) under the US Food and Drug Administration accelerated approval program, which warrants confirmatory evidence on long-term efficacy of droxidopa. Hereby, we synthesize evidence from published randomized controlled trials about the safety and efficacy of droxidopa for… Continue reading Congratulations (paper published)